Evidence map›Paper›PMID 20086048›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2010

Interferon-inducible factor 16 is a novel modulator of glucocorticoid action.

A Berry, L Matthews, M Jangani, J Plumb, S Farrow, N Buchan, P A Wilson, D Singh, D W Ray, R P Donn

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Betacoronavirus-specific alternate splicing.bioRxiv : the preprint server for biology · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

A BerryArthritis Research Campaign Epidemiology Unit, University of Manchester, Manchester, UK.
L Matthews
M Jangani
J Plumb
S Farrow
N Buchan
P A Wilson
D Singh
D W Ray
R P Donn
University of Manchester · GBNorth Hertfordshire College · GBAge UK · GB

Funding

Arthritis Research UK 16404Arthritis Research UK 17552Arthritis Research UK 17900Biotechnology and Biological Sciences Research CouncilMedical Research CouncilWellcome Trust 082979
6 · The paper itself

Abstract

Previously, we used cDNA expression profiling to identify genes associated with glucocorticoid (Gc) sensitivity. We now identify which of these directly influence Gc action. Interferon-inducible protein 16 (IFI16), bone morphogenetic protein receptor type II (BMPRII), and regulator of G-protein signaling 14 (RGS14) increased Gc transactivation, whereas sialyltransferase 4B (SIAT4B) had a negative effect. Amyloid beta (A4) precursor-protein binding, family B, member 1 (APBB1/Fe65) and neural cell expressed developmentally down-regulated 9 (NEDD9) were without effect. Only IFI16 potentiated Gc repression of NF-kappaB. In addition, IFI16 affected basal expression, and Gc induction of endogenous target genes. IFI16 did not affect glucocorticoid receptor (GR) expression, ligand-dependent repression of GR expression, or the ligand-dependent induction of GR phosphorylation on Ser-211 or Ser-203. Coimmunoprecipitation revealed an interaction, suggesting that IFI16 modulation of GR function is mediated by protein crosstalk. Transfection analysis with GR mutants showed that the ligand-binding domain of GR binds IFI16 and is the target domain for IFI16 regulation. Analysis of human lung sections identified colocalization of GR and IFI16, suggesting a physiologically relevant interaction. We demonstrate that IFI16 is a novel modulator of GR function and show the importance of analyzing variation in Gc sensitivity in humans, using appropriate technology, to drive discovery.

Indexed as

Adaptor Proteins, Signal TransducingBlotting, WesternBone Morphogenetic Protein Receptors, Type IICells, CulturedComputational BiologyFluorescent Antibody TechniqueGlucocorticoidsHumansImmunoblottingImmunoenzyme TechniquesImmunoprecipitationLung NeoplasmsNF-kappa BNuclear ProteinsPhosphoproteinsPhosphorylationAdaptor Proteins, Signal TransducingBMPR2 protein, humanBone Morphogenetic Protein Receptors, Type IIGlucocorticoidsIFI16 protein, humanNEDD9 protein, humanNF-kappa BNuclear ProteinsPhosphoproteinsReceptors, GlucocorticoidRGS14 protein, humanRGS ProteinsRNA, Messenger

Identifiers

PMID20086048
PMCPMC3000051
OpenAlexW2144500327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.